Prestige Biologics Ratios and Metrics

Market cap in millions KRW. Fiscal year is July - June.

Millions KRW. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2019
Period Ending	Aug '25 Aug 11, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2019
Market Capitalization	304,790	245,391	272,542	184,546	453,181	-	Upgrade
Market Cap Growth	16.04%	-9.96%	47.68%	-59.28%	-	-	Upgrade
Enterprise Value	385,561	378,645	369,331	283,846	447,789	-	Upgrade
Last Close Price	3920.00	3990.00	4460.00	3020.00	9600.00	-	Upgrade
PS Ratio	45.42	113.13	156.11	11855.95	140.44	-	Upgrade
PB Ratio	2.28	3.42	2.73	1.57	4.24	-	Upgrade
P/TBV Ratio	2.30	3.46	2.76	1.58	4.31	-	Upgrade
EV/Sales Ratio	57.45	174.57	211.55	18235.34	138.77	-	Upgrade
Debt / Equity Ratio	0.68	2.41	1.60	1.01	0.73	-19.80	Upgrade
Asset Turnover	-	0.01	-	0	0.03	-	Upgrade
Inventory Turnover	-	0.89	-	0.00	0.14	0.00	Upgrade
Quick Ratio	0.14	0.34	0.53	0.54	1.59	0.10	Upgrade
Current Ratio	0.45	0.60	0.79	0.92	1.93	0.18	Upgrade
Return on Equity (ROE)	-	-34.26%	-	-44.30%	-74.70%	-226.09%	Upgrade
Return on Assets (ROA)	-	-7.02%	-	-9.85%	-13.05%	-23.09%	Upgrade
Return on Capital (ROIC)	-	-8.28%	-	-10.87%	-15.88%	-34.78%	Upgrade
Earnings Yield	-10.81%	-11.97%	-14.47%	-26.94%	-8.69%	-	Upgrade
FCF Yield	-7.17%	-6.87%	-22.11%	-64.36%	-27.17%	-	Upgrade
Buyback Yield / Dilution	-18.92%	-4.43%	-13.35%	-16.44%	-25.46%	-11.46%	Upgrade

Updated Jan 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.